Comparing 6 vs 3 chemo cycles before surgery for thymus tumors
Part of Blood & lymphatic, Cancer, Lungs & breathing clinical trials.
This study compares 6 rounds versus 3 rounds of chemotherapy given before surgery for a thymus tumor. The goal is to see if fewer chemo cycles can shrink the tumor just as well, with fewer side effects, while still making surgery successful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of thymus gland tumor (thymoma or thymic carcinoma).
- Your tumor is locally advanced (stage III or IVA) but might still be removable with surgery.
- You are between 18 and 65 years old.
- You feel well enough for daily activities (ECOG score 0 or 1).
- You have not had prior chemo, radiation, or targeted therapy for this tumor.
- Your blood counts and kidney/liver function are adequate.
- You are willing to accept random assignment to 6 or 3 cycles of chemo before surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving radiation therapy before surgery for a type of thymus gland tumor (thymoma) that has grown into nearby tissues but has not been treated yet. The goal is to see if this approach can make the tumor removable and improve outcomes.
This trial tests whether additional chemotherapy after surgery can help prevent thymic cancer from coming back. It is for people who have had their thymus tumor completely removed and are in good health.
This trial combines surgery (burning away the tumor) with heated chemotherapy given directly into the chest to treat thymus gland tumors that have spread to the lining of the lung or chest wall. The goal is to remove the visible tumor and wash the area with heated chemo to help delay or prevent it from coming back.
This trial tests KC1036 in people with advanced thymoma or thymic carcinoma whose cancer came back or spread after their first standard chemotherapy. It may offer a new treatment option when earlier treatment no longer worked.
This study tests giving chemotherapy directly into the chest (intrathoracic) during or after surgery to remove pleura tumors in people with thymoma or thymic cancer. It aims to see if this approach can reduce the chance of the cancer coming back.
This trial compares adding immunotherapy to standard chemo-radiation before surgery for locally advanced, operable esophageal squamous cell cancer. It aims to improve how well the tumor responds and whether patients do better after surgery.
Hear when a new Thymoma and Thymic Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.